ImmunoGen, Inc. provided revenue guidance for 2022. For the period the Company expects revenues between $75 million and $85 million.
1st Jan change | Capi. | |
---|---|---|
+33.95% | 50.85B | |
+0.74% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.95% | 26.11B | |
-21.61% | 19.13B | |
+9.27% | 13.05B | |
+27.66% | 12.16B | |
+23.99% | 12.08B |